October 20, 2016SHILAP Revista de lepidopterologíaOpen Access

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

View Full Paper

Ask AI

Bookmark

Abstract

These results support the use of PI3K inhibitors to control T cell responses and show the potential utility of the dual PI3K/mTOR inhibitor BEZ235 in GvHD prophylaxis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Herrero‐Sánchez et al. (2016) studied this question.

synapsesocial.com/papers/69dd4b4bfb7610310c101b26 https://doi.org/10.1186/s13045-016-0343-5

View Full Paper

Ask AI

Bookmark

Abstract

These results support the use of PI3K inhibitors to control T cell responses and show the potential utility of the dual PI3K/mTOR inhibitor BEZ235 in GvHD prophylaxis.

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

Abstract

Discussion

Cite This Study

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

Abstract

Discussion

Cite This Study

Keep reading

Keep reading